cobas b 221 AutoQC Module Complete; Catalog numbers: 3313522001 and 3313522692 The Roche Diagn...

FDA Device Recall #Z-1613-2018 — Class II — February 22, 2018

Recall Summary

Recall Number Z-1613-2018
Classification Class II — Moderate risk
Date Initiated February 22, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Roche Diagnostics Corporation
Location Indianapolis, IN
Product Type Devices
Quantity 1026 total products

Product Description

cobas b 221 AutoQC Module Complete; Catalog numbers: 3313522001 and 3313522692 The Roche Diagnostics Omni S Analyzer is a fully automated critical care analyzer intended to be used for the measurement of pH, PCO2, PO2, sodium, potassium, ionized calcium, chloride, hematocrit, glucose, lactate, urea/BUN, total hemoglobin, oxygen saturation, oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin, and methemoglobin in samples of whole blood, serum, plasma, and aqueous solutions as appropriate.

Reason for Recall

The software responsible for starting scheduled AutoQC measurements (scheduler) will not activate.

Distribution Pattern

USA ( nationwide)

Lot / Code Information

Catalog numbers: 3313522001 and 3313522692

Other Recalls from Roche Diagnostics Corporation

Recall # Classification Product Date
Z-1979-2019 Class II The Tina-quant lgA Gen.2 is an immunoturbidimet... Jun 3, 2019
Z-1928-2019 Class III cobas p 701 post-analytical units, Part Number ... Apr 4, 2019
Z-1927-2019 Class III cobas p 501 post-analytical units, Part Number ... Apr 4, 2019
Z-1194-2019 Class II Albumin BCP Product Usage: ALBP is an in v... Mar 18, 2019
Z-1249-2019 Class II cobas e 801 immunoassay analyzer Mar 15, 2019

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.